Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

2 Pros, 2 Cons for Buying Energy Transfer Right Now

By Josh Enomoto, InvestorPlace Contributor

With the markets starving for yield, a passive-income monster like ET stock may offer relief. However, do note the pros and cons before diving in.

Don’t Make a Blind Investment In Ocugen Stock

By Josh Enomoto, InvestorPlace Contributor

After Ocugen recently disappointed in a late-stage trial for one of its therapies, OCGN stock jumped higher. Is this a legitimate rally or merely a dead cat bounce?

Don’t Cancel Your Visit With Co-Diagnostics Stock Just Yet

By Josh Enomoto, InvestorPlace Contributor

CODX stock took a hit as economic indicators suggested a sooner-than-expected recovery. But don’t completely ignore shares just yet.

Why Inovio Pharmaceuticals May Get a Pass on Coronavirus Vaccine Hype

By Josh Enomoto, InvestorPlace Contributor

INO stock has its fair share of critics and under normal circumstances, those criticisms could cripple it. However, these are not normal circumstances.

Don’t Buy Royal Caribbean Cruises’ False Narrative

By Josh Enomoto, InvestorPlace Contributor

RCL stock along with the cruise ship industry has enjoyed remarkable bullishness recently. Unfortunately, the economic backdrop suggests this optimism is unjustified.

Nokia Is a Cynical Beneficiary of the Trump Administration

By Josh Enomoto, InvestorPlace Contributor

For years, Nokia stock has been a frustrating investment. But with geopolitical tensions pressuring the telecom equipment industry’s top contender, NOK looks mighty interesting for the contrarian.

General Electric is Losing Credibility Amid Multiple Crises

By Josh Enomoto, InvestorPlace Contributor

GE stock was already a challenging recovery story before the pandemic. But with the coronavirus decimating air travel, this narrative became all the more difficult.

7 Stocks to Short Now to Make Big Money

By Josh Enomoto, InvestorPlace Contributor

Many publicly traded companies are moving higher simply off a rising tide. Thus, this is an ideal time to consider stocks to short.

IBIO Will Continue to Power Higher on Its Superior Scalability

By Josh Enomoto, InvestorPlace Contributor

IBIO stock is hardly alone as a direct play on the coronavirus vaccine industry. Nevertheless, the company separates itself from the muck with its proprietary ability to scale up solutions.

Moderna May Not Be What Speculators Thought

By Josh Enomoto, InvestorPlace Contributor

With demand sky-high for a coronavirus vaccine, it was only natural that MRNA stock jumped higher on Moderna’s encouraging early stage clinical trial results. However, its questionable practices are now coming into closer view.

Load More